‘Imitinef Mercilet’ curing Blood Cancer!! Hoax

I just received a mail in the mail Which is is as follows:

Dear All, Please send to your colleagues and friends as many you can. Do not delete without sending to anybody. I have forwarded it to the maximum I can. Let it reach the 110 crores Indians and the remaining if any. ‘Imitinef Mercilet’ is a medicine which cures blood cancer. Its available free of cost at “Adyar Cancer Institute in Chennai”. Create Awareness. It might help someone.   Forward to as many as u can, kindness costs  nothing.

Just revealing a fact about this.

Please don’t forward this without being ignorant as this seems to be a hoax. This seemed too good to be true so I googled a little and found out the following:

According to this message, India’s Adyar Cancer Institute is distributing, free of charge, a medicine named ‘Imitinef Mercilet’ that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.
‘Imitinef Mercilet’ is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a “Gleevec”, has proved to be an effective treatment for some forms of cancers. However, “blood cancer” is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.
According to this message, India’s Adyar Cancer Institute is distributing, free of charge, a medicine named ‘Imitinef Mercilet’ that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.
The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.
I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:
Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.
‘Imitinef Mercilet’ is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a “Gleevec”, has proved to be an effective treatment for some forms of cancers. However, “blood cancer” is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.
Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.
Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.